Join our daily newsletter At The Bell to receive exclusive market insights
The ASX is expected to open lower after mixed results on the global markets overnight.
Eyes are on the Reserve Bank today as it prepares to explain its decision over the rates hikes pause in April during meeting minutes on Tuesday.
Nonetheless, here are some ASX-listed companies to look out for during Monday’s trade:
Critical Resources (CRR) has struck multiple thick near-surface spodumene mineralisation intercepts at its Mavis Lake lithium project in Canada.
Standout hits included 10.65 metres of spodumene mineralisation from three metres downhole, 7.65 metres of mineralisation from 3.1 metres downhole and 11.3 metres of mineralisation from 13.3 metres downhole.
The intercepts were from both the central Main Zone and the South Zone of Mavis Lake.
Shares in CRR last traded at 3.8 cents.
Peak Rare Earths (PEK) has signed a binding agreement with the Government of Tanzania for its Ngualla rare earth project.
The agreement covers the licencing, development, economic benefit sharing and the formation of a joint venture between the company and the Government concerning the project.
PEK Executive Chair Russel Scrimshaw said the company was “delighted” to partner with the Government of Tanzania.
“Development of the Ngualla project will deliver direct foreign investment of more than US$320 million into the Tanzanian economy, generate hundreds of direct and thousands of indirect jobs for Tanzanians and position Tanzania as one of the major rare earth producers outside of China,” Mr Scrimshaw said.
Shares in PEK last traded at 66 cents.
Meanwhile, Evolution Energy Minerals (EV1) has also inked a contract with the Tanzanian Government.
The company confirmed it entered agreements over its Chilalo graphite project.
The agreements cover the ownership, development and management of Evolution’s project.
“With these agreements now in place, we look forward to working together with the Government of Tanzania to establish a commercial scale graphite mine that delivers meaningful benefits to all stakeholders,” Evolution Managing Director Phill Hoskins said.
Shares in EV1 last traded at 26 cents.
Emyria (EMD) has announced it will continue its collaboration with psychiatrist-led medical practice PAX Centre and develop a care model for psilocybin-assisted therapy.
The new care model will complement its existing MDMA-assisted therapy care model, addressing the overlap between symptoms of PTSD and major depression.
EMD and PAX Centre have also called on Dr Ben Sessa, a prominent psychiatrist and MDMA researcher with more than 20 years of experience in psychiatry, to provide expertise and training support.
Shares in EMD last traded at 16 cents.
Lord Resources (LRD) has intersected pegmatite in 47 out of 52 holes as part of its recently-completed reverse circulation (RC) drilling program for 4223 metres.
The program at its Horse Rocks lithium project logged a total of 157 pegmatite intervals across the 47 holes for a total of 1016 metres of logged pegmatite.
The company confirmed a full suite of assays is expected in the coming weeks.
Shares in LRD last traded at 26 cents.
